Newsletter | November 2, 2026

11.02.26 -- AI Can't Fix Enrollment When Payments, Sites, And Trust Break Down

PATIENT CENTRICITY

Can Psychedelic‑Assisted Treatment Redefine Emotional Care In Oncology?

Psychedelic-assisted treatment may offer faster, lasting relief for cancer patients facing adjustment disorder, depression, and anxiety.

Unifying Research - Patient Negative One And Christine Von Raesfeld

Clinical research innovation and patient advocacy meet in a conversation about AI, ethics, autonomy, and trust, highlighting how bold ideas and lived experience help shape a more responsible future.

Where Clinical Trial Reimbursement Gets Complicated

Learn where participant reimbursement can break down in clinical trials and how clearer payment processes can reduce delays and unnecessary work for research sites.

Why Fee-Free Trial Participant Payments Always Pay Off

Remove the administrative burden of clinical trials for patients while ensuring compliance and offering global accessibility.

PATIENT RECRUITMENT

AI Can Help Design Better Trials, But It Can't Tell You Whether Patients Will Join Them

AI is changing the way clinical trial trials are discussed, planned, and designed. But even with an improved protocol, are AI-enhanced trials driving better enrollment?

The Power Of Partnership: Connecting With 1M+ Patients

Embedding studies within a health system's community hospitals gives sponsors a route to patients already in care, with implications for referral pathways and enrollment speed.

Patient Retention In Clinical Trials And Recruitment Support

Accelerate clinical trials with expert patient recruitment strategies delivering faster enrollment, lower dropout rates, and better outcomes.

CLINICAL SITES

What I Heard When I Crashed Three ING Dive Teams

After attending three Innovation Network Gathering Dive Teams, Chief Editor Dan Schell shares what he heard about accelerating study startup, rethinking investigator meetings, and leading through AI adoption—along with a reminder that promising ideas still need stakeholder support, measurable evidence, and practical execution.

Collaborate To Improve The Patient Experience

Fragmented trial operations trigger costly enrollment delays. Discover how operational alignment among sponsors, CROs, and site networks drives patient retention and study success.

Early Phase Oncology Site Network: Benefits Of A Personal Touch

Choose a site network built on partnership — not volume — to drive smoother early-phase oncology trials and deliver better outcomes for sponsors, sites, and patients.

Benefit From Enhanced Power And Intelligence

Find a supply automation value engine with intelligent automation and algorithms to analyze drug supply data and automatically adjust delivery quantities to each site based on data available in IRT.

Connect With Clinical Leader: